President Donald Trump and Daniel O'Day, CEO of Gillead Sciences Inc. meet at White House
Celebrity Pictures > Archives > 2020 > May >
President Donald Trump and Daniel O'Day, CEO of Gillead Sciences Inc. meet at White House (21 pictures)
View All Images- United States President Donald J. Trump speaks during a meeting with Daniel O'Day, CEO of Gilead Sciences Inc. at the White House in Washington,DC after regulators allowed emergency use of a drug made by Gilead Sciences Inc. which has been shown to help patients suffering from Covid-19 on Friday, May 1, 2020. Credit: Erin Schaff / Pool via CNP/AdMedia
- United States Vice President Mike Pence, left, listens as Daniel O'Day, CEO of Gilead Sciences Inc., right, speaks during a meeting with United States President Donald Trump at the White House in Washington,DC after regulators allowed emergency use of a drug made by Gilead Sciences Inc. which has been shown to help patients suffering from Covid-19 on Friday, May 1, 2020. Credit: Erin Schaff / Pool via CNP/AdMedia
- United States Secretary of Health and Human Services (HHS) Alex Azar attends a meeting with United States President Donald Trump and Daniel O'Day, CEO of Gilead Sciences Inc. at the White House in Washington,DC after regulators allowed emergency use of a drug made by Gilead Sciences Inc. which has been shown to help patients suffering from Covid-19 on Friday, May 1, 2020. Credit: Erin Schaff / Pool via CNP/AdMedia
- United States President Donald J. Trump participates in a meeting with Daniel O'Day, CEO of Gilead Sciences Inc. at the White House in Washington,DC after regulators allowed emergency use of a drug made by Gilead Sciences Inc. which has been shown to help patients suffering from Covid-19 on Friday, May 1, 2020. Credit: Erin Schaff / Pool via CNP/AdMedia
- United States President Donald J. Trump participates in a meeting with Daniel O'Day, CEO of Gilead Sciences Inc. at the White House in Washington,DC after regulators allowed emergency use of a drug made by Gilead Sciences Inc. which has been shown to help patients suffering from Covid-19 on Friday, May 1, 2020. Credit: Erin Schaff / Pool via CNP/AdMedia
- United States Vice President Mike Pence, left, listens as Daniel O'Day, CEO of Gilead Sciences Inc., right, speaks during a meeting with United States President Donald Trump at the White House in Washington,DC after regulators allowed emergency use of a drug made by Gilead Sciences Inc. which has been shown to help patients suffering from Covid-19 on Friday, May 1, 2020. Credit: Erin Schaff / Pool via CNP/AdMedia
- Daniel O'Day, CEO of Gilead Sciences Inc., center, speaks during a meeting with United States President Donald J. Trump, right, and US Vice President Mike Pence, left, after regulators allowed emergency use of a drug made by Gilead Sciences Inc. which has been shown to help patients suffering from Covid-19 on Friday, May 1, 2020. Credit: Erin Schaff / Pool via CNP/AdMedia
- Daniel O'Day, CEO of Gilead Sciences Inc., center, speaks during a meeting with United States President Donald J. Trump, right, and United States Vice President Mike Pence, left, at the White House in Washington,DC after regulators allowed emergency use of a drug made by Gilead Sciences Inc. which has been shown to help patients suffering from Covid-19 on Friday, May 1, 2020. Credit: Erin Schaff / Pool via CNP/AdMedia
- Daniel O'Day, CEO of Gilead Sciences Inc., center, speaks during a meeting with United States President Donald J. Trump, right, and United States Vice President Mike Pence, left, at the White House in Washington,DC after regulators allowed emergency use of a drug made by Gilead Sciences Inc. which has been shown to help patients suffering from Covid-19 on Friday, May 1, 2020. Credit: Erin Schaff / Pool via CNP/AdMedia
- United States President Donald J. Trump participates in a meeting with Daniel O'Day, CEO of Gilead Sciences Inc. at the White House in Washington,DC after regulators allowed emergency use of a drug made by Gilead Sciences Inc. which has been shown to help patients suffering from Covid-19 on Friday, May 1, 2020. Credit: Erin Schaff / Pool via CNP/AdMedia
- United States President Donald J. Trump participates in a meeting with Daniel O'Day, CEO of Gilead Sciences Inc. at the White House in Washington,DC after regulators allowed emergency use of a drug made by Gilead Sciences Inc. which has been shown to help patients suffering from Covid-19 on Friday, May 1, 2020. Credit: Erin Schaff / Pool via CNP/AdMedia
- United States President Donald J. Trump participates in a meeting with Daniel O'Day, CEO of Gilead Sciences Inc. at the White House in Washington,DC after regulators allowed emergency use of a drug made by Gilead Sciences Inc. which has been shown to help patients suffering from Covid-19 on Friday, May 1, 2020. Credit: Erin Schaff / Pool via CNP/AdMedia
- Dr. Deborah L. Birx, White House Coronavirus Response Coordinator, left, and United States Secretary of Health and Human Services (HHS) Alex Azar, right, listen during a meeting with Daniel O'Day, CEO of Gilead Sciences Inc., and President Donald Trump at the White House in Washington,DC after regulators allowed emergency use of a drug made by Gilead Sciences Inc. which has been shown to help patients suffering from Covid-19 on Friday, May 1, 2020. Credit: Erin Schaff / Pool via CNP/AdMedia
- United States President Donald J. Trump participates in a meeting with Daniel O'Day, CEO of Gilead Sciences Inc. at the White House in Washington,DC after regulators allowed emergency use of a drug made by Gilead Sciences Inc. which has been shown to help patients suffering from Covid-19 on Friday, May 1, 2020. Credit: Erin Schaff / Pool via CNP/AdMedia
- United States President Donald J. Trump participates in a meeting with Daniel O'Day, CEO of Gilead Sciences Inc. at the White House in Washington,DC after regulators allowed emergency use of a drug made by Gilead Sciences Inc. which has been shown to help patients suffering from Covid-19 on Friday, May 1, 2020. Credit: Erin Schaff / Pool via CNP/AdMedia
- Dr. Deborah L. Birx, White House Coronavirus Response Coordinator, right center, speaks during a meeting with United States President Donald J. Trump, left, Stephen Hahn, Commissioner, United States Food and Drug Administration (FDA), center left, and United States Secretary of Health and Human Services (HHS) Alex Azar, right, and Daniel O'Day, CEO of Gilead Sciences Inc. at the White House in Washington,DC at the White House in Washington,DC after regulators allowed emergency use of a drug made by Gilead Sciences Inc. which has been shown to help patients suffering from Covid-19 on Friday, May 1, 2020. Credit: Erin Schaff / Pool via CNP/AdMedia
- White House Press Secretary Kayleigh McEnany, left, and Jared Kushner, Assistant to the President and Senior Advisor, right, listen during a meeting with United States President Donald J. Trump and Daniel O'Day, CEO of Gilead Sciences Inc., at the White House in Washington,DC after regulators allowed emergency use of a drug made by Gilead Sciences Inc. which has been shown to help patients suffering from Covid-19 on Friday, May 1, 2020. Credit: Erin Schaff / Pool via CNP/AdMedia
- White House Press Secretary Kayleigh McEnany, left, and Jared Kushner, Assistant to the President and Senior Advisor, right, listen during a meeting with United States President Donald J. Trump and Daniel O'Day, CEO of Gilead Sciences Inc., at the White House in Washington,DC after regulators allowed emergency use of a drug made by Gilead Sciences Inc. which has been shown to help patients suffering from Covid-19 on Friday, May 1, 2020. Credit: Erin Schaff / Pool via CNP/AdMedia
- White House Press Secretary Kayleigh McEnany, left, and Jared Kushner, Assistant to the President and Senior Advisor, right, listen during a meeting with United States President Donald J. Trump and Daniel O'Day, CEO of Gilead Sciences Inc., at the White House in Washington,DC after regulators allowed emergency use of a drug made by Gilead Sciences Inc. which has been shown to help patients suffering from Covid-19 on Friday, May 1, 2020. Credit: Erin Schaff / Pool via CNP/AdMedia
- Deputy Assistant to the President for Operations and Personal Aide to the President Nicholas Luna, right, White House Press Secretary Kayleigh McEnany, center, and Jared Kushner, Assistant to the President and Senior Advisor listen during a meeting with United States President Donald Trump and Daniel O'Day, CEO of Gilead Sciences Inc. at the White House in Washington,DC after regulators allowed emergency use of a drug made by Gilead Sciences Inc. which has been shown to help patients suffering from Covid-19 on Friday, May 1, 2020. Credit: Erin Schaff / Pool via CNP/AdMedia
- Deputy Assistant to the President for Operations and Personal Aide to the President Nicholas Luna, right, White House Press Secretary Kayleigh McEnany, center, and Jared Kushner, Assistant to the President and Senior Advisor listen during a meeting with United States President Donald Trump and Daniel O'Day, CEO of Gilead Sciences Inc. at the White House in Washington,DC after regulators allowed emergency use of a drug made by Gilead Sciences Inc. which has been shown to help patients suffering from Covid-19 on Friday, May 1, 2020. Credit: Erin Schaff / Pool via CNP/AdMedia `